To explore the clinicopathological implications of single positive core prostate cancer.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
A total of 45 patients with transrectal ultrasound (TRUS)-guided prostate biopsy were diagnosed with single positive core prostate cancer and subsequently underwent radical prostatectomy (RP).
Their clinicopathological parameters were examined to identify the factors for disease upgrading or upstaging.
On final pathology, only 31. 1% patients had unilateral prostate cancer. And 37. 8% patients experienced Gleason score upgrading, 66. 7% patients had upstaging and 31. 1% were found positive surgical margins. On multivariable analyses, the percentage of positive cores was an independent predictor of stage upgrading and perineural invasion at RP pathology. Age, prostate volume and preoperative prostate-specific antigen/prostate-specific antigen density (PSA/PSAD) had no significant effect on underestimated tumor burden.
Most single positive core prostate cancer diagnosed by 12-core biopsy may be underestimated. The percentage of positive cores is an independent predictor of underestimated prostate cancer. Currently we have no instruments for accurately identifying microfocal or unilateral prostate cancer.
Zhonghua yi xue za zhi. 2015 May 26 [Epub]
Mingxin Zhang, Rong Yang, Wei Wang, Xiaogong Li, Yifen Zhang, Hongqian Guo
Department of Urology, Affiliated Drum Tower Hospital, Nanjing University Medical School, Nanjing 210008, China.